Compositions useful as inhibitors of protein kinases
    7.
    发明授权
    Compositions useful as inhibitors of protein kinases 失效
    可用作蛋白激酶抑制剂的组合物

    公开(公告)号:US08642779B2

    公开(公告)日:2014-02-04

    申请号:US12634136

    申请日:2009-12-09

    摘要: The present invention provides compounds of formula I: or a pharmaceutically acceptable derivative thereof, wherein A, B, Q, R1, and R2 are as described in the specification. These compounds are inhibitors of protein kinase, particularly inhibitors of AKT or PDK1 kinase, mammalian protein kinases involved in proliferative and neurodegenerative disorders. The invention also provides pharmaceutical compositions comprising the compounds of the invention, processes for preparing the compounds, and methods of utilizing those compositions in the treatment of various disorders.

    摘要翻译: 本发明提供式I化合物或其药学上可接受的衍生物,其中A,B,Q,R 1和R 2如说明书中所述。 这些化合物是蛋白激酶的抑制剂,特别是AKT或PDK1激酶的抑制剂,涉及增殖和神经变性疾病的哺乳动物蛋白激酶。 本发明还提供包含本发明化合物的药物组合物,制备化合物的方法,以及利用这些组合物治疗各种疾病的方法。

    PYRROLOPYRAZINES AND PYRAZOLOPYRAZINES USEFUL AS INHIBITORS OF PROTEIN KINASES
    9.
    发明申请
    PYRROLOPYRAZINES AND PYRAZOLOPYRAZINES USEFUL AS INHIBITORS OF PROTEIN KINASES 审中-公开
    作为蛋白激酶的抑制剂有用的吡咯并吡嗪和吡唑并吡咯

    公开(公告)号:US20130096302A1

    公开(公告)日:2013-04-18

    申请号:US13650586

    申请日:2012-10-12

    IPC分类号: C07D487/04

    CPC分类号: C07D487/04

    摘要: The present invention relates to compounds useful as inhibitors of Aurora protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.

    摘要翻译: 本发明涉及可用作Aurora蛋白激酶抑制剂的化合物。 本发明还提供包含所述化合物的药学上可接受的组合物和使用该组合物治疗各种疾病,病症或病症的方法。 本发明还提供了制备本发明化合物的方法。